INBRAIN Neuroelectronics
INBRAIN Neuroelectronics is pioneering real time precision neurology with the world’s first graphene-based brain-computer interface (BCI) therapeutics platform. Our technology combines precise BCI decoding with micrometric modulation to deliver adaptive, personalized treatments for conditions such as Parkinson’s disease, epilepsy, and stroke rehabilitation. By providing continuous real-time monitoring and autonomous therapy adjustments, our AI-driven platform maximizes therapeutic outcomes while minimizing side effects. Through strategic collaborations, including with Merck KGAa and our subsidiary INNERVIA Bioelectronics, we are extending our innovative solutions to peripheral nerve and systemic disease applications, unlocking the potential of neurotechnology and bioelectronics. For more information, visit www.inbrain-neuroelectronics.com and follow us on LinkedIn.
Domain
inbrain-neuroelectronics.com
Country
SpainIndustry
BiotechnologyEmployees
51-100
Last Funding
$4.5M
Founded
2020
Tech Stack (18 technologies)
Frequently Asked Questions
What technologies does INBRAIN Neuroelectronics use?+
INBRAIN Neuroelectronics uses 18 technologies including Bootstrap, Contact Form 7, Flockler.
What industry is INBRAIN Neuroelectronics in?+
INBRAIN Neuroelectronics operates in the Biotechnology industry.
Where is INBRAIN Neuroelectronics based?+
INBRAIN Neuroelectronics is headquartered in Spain.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026